VNDRIQ — Vendor Comparison
Anomaly vs Adentris
Side-by-side comparison of BAA status, PHI exposure, AI training risk, HIPAA suitability, and VNDRIQ governance scores.
Anomaly
Revenue Cycle AI
Last verified: September 30, 2026
Adentris
Revenue Cycle AI
Last verified: September 30, 2026
VNDRIQ Scores
53
Overall
53
Overall
Approval Tier
BAA Status
PHI Exposure Risk
AI Training Risk
HIPAA Risk Level
Review Frequency
—
—
Recommended Use
—
—
Restrictions
—
—
Executive Summary
Anomaly
Revenue Cycle AI
Anomaly is classified as Restricted / Review Required with a BAA status of Verify Directly. PHI exposure is rated Medium and AI training risk is Medium.
62
Privacy
33
Governance
50
Healthcare
65
AI Risk
Adentris
Revenue Cycle AI
Adentris is classified as Restricted / Review Required with a BAA status of Verify Directly. PHI exposure is rated Medium and AI training risk is Medium.
62
Privacy
33
Governance
50
Healthcare
65
AI Risk
Recommended For
Anomaly
Currently under review — not recommended for active PHI deployment
Adentris
Currently under review — not recommended for active PHI deployment
Governance Considerations
Anomaly
BAA has not been confirmed. Execute BAA before processing PHI.
Adentris
BAA has not been confirmed. Execute BAA before processing PHI.
Questions to Ask Before Approval
Has the vendor executed a Business Associate Agreement (BAA) with your organization?
Does the vendor use customer data to train AI models? Can you opt out?
Where is PHI stored, processed, and transmitted?
What data retention and deletion policies apply to your PHI?
Has the vendor undergone a third-party HIPAA or SOC 2 audit?
What is the vendor's incident response and breach notification process?
Does the vendor offer audit logging for PHI access?
What subprocessors have access to PHI through this vendor?
Request Vendor Evaluation
Get a structured risk assessment for any vendor.
Request Benchmark Report
Compare vendors across your full stack.
Book Governance Assessment
Talk to a VNDRIQ governance specialist.